GQG Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$409K Sell
5,923
-111,202
-95% -$7.67M ﹤0.01% 86
2025
Q1
$8.13M Sell
117,125
-12,877,408
-99% -$894M 0.01% 62
2024
Q4
$1.12B Buy
12,994,533
+5,556,460
+75% +$478M 1.66% 22
2024
Q3
$886M Buy
7,438,073
+3,223,857
+76% +$384M 1.39% 28
2024
Q2
$602M Buy
4,214,216
+581,152
+16% +$83M 0.91% 30
2024
Q1
$466M Buy
3,633,064
+3,151,584
+655% +$405M 0.75% 30
2023
Q4
$49.8M Buy
481,480
+75,344
+19% +$7.79M 0.11% 42
2023
Q3
$36.9M Buy
406,136
+17,046
+4% +$1.55M 0.09% 42
2023
Q2
$31.5M Sell
389,090
-59,232
-13% -$4.79M 0.07% 39
2023
Q1
$35.7M Buy
448,322
+55,158
+14% +$4.39M 0.09% 42
2022
Q4
$26.6M Buy
393,164
+23,350
+6% +$1.58M 0.07% 53
2022
Q3
$18.4M Buy
369,814
+97,574
+36% +$4.86M 0.05% 50
2022
Q2
$15.2M Sell
272,240
-29,654
-10% -$1.65M 0.04% 50
2022
Q1
$16.8M Buy
301,894
+11,420
+4% +$634K 0.04% 48
2021
Q4
$16.3M Buy
290,474
+60,614
+26% +$3.39M 0.04% 54
2021
Q3
$11M Buy
229,860
+5,138
+2% +$247K 0.03% 48
2021
Q2
$9.41M Sell
224,722
-17,344
-7% -$726K 0.03% 46
2021
Q1
$8.16M Sell
242,066
-25,894
-10% -$873K 0.03% 50
2020
Q4
$9.36M Buy
267,960
+211,182
+372% +$7.38M 0.03% 51
2020
Q3
$1.97M Buy
56,778
+1,690
+3% +$58.7K 0.01% 59
2020
Q2
$1.8M Sell
55,088
-1,626
-3% -$53.2K 0.01% 54
2020
Q1
$1.71M Buy
56,714
+42,132
+289% +$1.27M 0.01% 51
2019
Q4
$422K Buy
+14,582
New +$422K ﹤0.01% 47
2018
Q1
Sell
-20,400
Closed -$547K 59
2017
Q4
$547K Hold
20,400
0.02% 50
2017
Q3
$491K Hold
20,400
0.02% 52
2017
Q2
$437K Buy
+20,400
New +$437K 0.03% 47